Second FDA panel advises on stimulants.
D026683:Advisory Committees; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D016757:Death, Sudden, Cardiac / Q000209:etiology; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D006212:Hallucinations / Q000139:chemically induced*; D008774:Methylphenidate / Q000009:adverse effects; D014481:United States; D014486:United States Food and Drug Administration
D000697:Central Nervous System Stimulants; D008774:Methylphenidate